(Q28185519)

2

0 references

Shuba Krishna

4

0 references

Srilatha Raghuram

6

0 references

David T. Denhardt

1

0 references

Joseph F. Porter

5

0 references

Susan R. Rittling

Clinical & Experimental Metastasis

7

0 references

language of work or name

English

0 references

publication date

2003

0 references

published in

0 references

volume

20

0 references

page(s)

77-84

0 references

issue

1

0 references

cites work

A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.

1 reference

12 December 2020

Osteopontin: a versatile regulator of inflammation and biomineralization

1 reference

12 December 2020

The functional and clinical roles of osteopontin in cancer and metastasis.

1 reference

12 December 2020

Osteopontin expression and distribution in human carcinomas.

1 reference

12 December 2020

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

1 reference

12 December 2020

The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model

1 reference

12 December 2020

Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors

1 reference

12 December 2020

Osteopontin expression in a group of lymph node negative breast cancer patients

1 reference

12 December 2020

Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.

1 reference

12 December 2020

Characterization of the rat osteopontin gene. Evidence for two vitamin D response elements.

1 reference

12 December 2020

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

1 reference

12 December 2020

Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line

1 reference

12 December 2020

Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Identification of positive and negative regulatory elements and a 'silent' second promoter

1 reference

12 December 2020

Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin

1 reference

12 December 2020

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

1 reference

12 December 2020

CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis

1 reference

12 December 2020

Osteopontin: a protein with diverse functions.

1 reference

12 December 2020

The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway

1 reference

12 December 2020

Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

1 reference

12 December 2020

Osteopontin as a potential diagnostic biomarker for ovarian cancer

1 reference

12 December 2020

ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancer

1 reference

12 December 2020

Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice

1 reference

12 December 2020

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.

1 reference

12 December 2020

Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts

1 reference

12 December 2020

Metastasis from human breast cancer cell lines

1 reference

12 December 2020

Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.

1 reference

12 December 2020

Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent

1 reference

12 December 2020

The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype

1 reference

12 December 2020

Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels

1 reference

12 December 2020

Tumor-derived osteopontin is soluble, not matrix associated

1 reference

12 December 2020

Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis

1 reference

12 December 2020

The role of osteopontin in tumorigenesis and metastasis.

1 reference

12 December 2020

Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation

1 reference

12 December 2020

A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes

1 reference

12 December 2020

The role of osteopontin in breast cancer: clinical and experimental studies

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin

1 reference

12 December 2020

Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases

1 reference

12 December 2020

Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells

1 reference

12 December 2020

Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell

1 reference

12 December 2020

Ras-responsive genes and tumor metastasis

1 reference

12 December 2020

Signaling pathways in Ras-mediated tumorigenicity and metastasis.

1 reference

12 December 2020

Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival

1 reference

12 December 2020

Genes that regulate metastasis and angiogenesis

1 reference

12 December 2020

Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)

1 reference

12 December 2020

Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts

1 reference

12 December 2020

Osteopontin expression and function: role in bone remodeling

1 reference

12 December 2020

Osteopontin as a biomarker for ovarian cancer

1 reference

12 December 2020

Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo

1 reference

12 December 2020

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

1 reference

12 December 2020

Overexpression of osteopontin in hepatocellular carcinoma

1 reference

12 December 2020

Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.

1 reference

12 December 2020

Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4.

1 reference

12 December 2020

Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo

1 reference

12 December 2020

Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.

1 reference

12 December 2020

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

1 reference

12 December 2020

Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein?

1 reference

12 December 2020

The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone

1 reference

12 December 2020

1 reference

12 December 2020

ras oncogenes in human cancer: a review

1 reference

12 December 2020

Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women

1 reference

12 December 2020

Osteopontin induces angiogenesis of murine neuroblastoma cells in mice

1 reference

12 December 2020

Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue

1 reference

12 December 2020

Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues

1 reference

12 December 2020

Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency

1 reference

12 December 2020

Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells.

1 reference

12 December 2020

Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

1 reference

12 December 2020

A unified theory of gene expression

1 reference

12 December 2020

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

1 reference

12 December 2020

Osteopontin expression in lung cancer

1 reference

12 December 2020

Osteopontin-induced modifications of cellular functions.

1 reference

12 December 2020

Upstream stimulatory factor 1 regulates osteopontin expression in smooth muscle cells

1 reference

12 December 2020

Cloning and characterization of the human osteopontin gene and its promoter

1 reference

12 December 2020

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

1 reference

12 December 2020

Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack

1 reference

12 December 2020

The metastasis gene osteopontin: a candidate target for cancer therapy

1 reference

12 December 2020

Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice

1 reference

12 December 2020

Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis

1 reference

12 December 2020

Ras regulation of vascular endothelial growth factor and angiogenesis

1 reference

12 December 2020

Osteopontin function in pathology: lessons from osteopontin-deficient mice.

1 reference

12 December 2020

Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene.

1 reference

12 December 2020

Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines.

1 reference

12 December 2020

Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers

1 reference

12 December 2020

Characterization of the chicken osteopontin-encoding gene.

1 reference

12 December 2020

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

1 reference

12 December 2020

Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease

1 reference

12 December 2020

Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4.

1 reference

12 December 2020

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

1 reference

12 December 2020

Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages.

1 reference

12 December 2020

Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin

1 reference

12 December 2020